Skip to main content

Featured

Stellantis May Abandon Brampton for Good: What It Means for Ontario Jobs

  Published August 18, 2026 With less than 24 hours left before Washington's 50% tariff deadline hits at 12:01 a.m. Wednesday, the headlines are all about cement, wine, and dairy. But the real fight holding up a deal is happening in the auto sector — and this week it collided with a story much closer to home: Stellantis is weighing whether to walk away from its Brampton, Ont. assembly plant for good. Put those two stories together and you get a clearer picture of what's actually at stake for Ontario workers, renters, and taxpayers than any tariff-deadline countdown can show on its own. The Trade Deal Is Stuck on Auto Rules, Not Wine or Cement Canadian and U.S. negotiators have been in Washington for a week trying to head off Trump's Section 338 tariffs — a rarely used trade law that, unlike earlier rounds, doesn't recognize USMCA certificates of origin for the goods it covers. Autos, alcohol, and dairy are all on the list, but autos are the sticking point. Canada is pu...

article

IVF Mix-Up: Australian Woman Gives Birth to Stranger's Baby

In a rare and distressing incident, an Australian woman gave birth to a child conceived from another couple's embryo due to a mix-up at a fertility clinic. The error occurred at Monash IVF's Brisbane clinic, one of Australia's leading fertility providers, and was attributed to "human error" during the embryo transfer process.

The mistake was discovered months after the birth when the parents requested to transfer their remaining embryos to another clinic. An investigation revealed that an additional embryo in storage belonged to another patient, confirming the mix-up. Monash IVF has since issued an apology and pledged to support the affected families through this challenging time.

This incident has sparked discussions about the need for stricter regulations and protocols in IVF clinics to prevent such errors in the future. While rare, similar cases have been reported globally, highlighting the importance of transparency and accountability in fertility treatments.



Comments